3-(5-Methylthiophen-2-yl)-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

3-Bromo-2-chloro-4-ethoxypyridine, 97%, 250mg

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 5g

EDTA-Manganese disodium salt x 2H2O, min. 93%, for synthesis, 250 g, plastic packaging.

4-Methyl-3-cyclohexene-1-carboxylic Acid>98.0%(GC)(T)5g

Regorafénib N-oxyde (M2), 10mg

2-chloro-4-(3-nitrophenoxy)thieno[3,2-d]pyrimidine, 97.0%, 1g

1-[2-(dimethylamino)ethyl]-2,3-dihydro-1h-indole-2,3-dione, 95%, 1g

N-(3-chlorophenyl)-4-methylbenzenesulfonamide, 98%, 1g

Pyrazine-2,6-diamine hydrochloride, 95.0%, 10g

Dimethylcyanamide>98.0%(GC)25mL

1-Methyl-2-piperidinemethanol, 95.0%, 25g

2,2-diethylmorpholine, 95.0%, 1g